Seegala Seegala
Seegala Seegala
  • NEWS
    • PRESS RELEASE
  • BUSINESS
    • CRYPTO
    • ECONOMY
    • FINANCE
    • MARKET
    • MONEY
  • TECH
    • APPS
    • GADGET
    • GAMING
    • MOBILE
    • SCIENCE
  • SOCIAL MEDIA
  • ENTERTAINMENT
    • ARTS & THEATER
    • GAMBLING
    • GAMING
    • MUSIC
    • MOVIE
    • SHOWS
    • SPORTS
  • BLOGS
  • LIFESTYLE
    • CELEBRITY
    • CULTURE
    • EDUCATION
    • FASHION
    • FOOD
    • HEALTH
    • NATURE
    • RELIGION
    • SHOPPING
    • TRAVEL
  • BUSINESS
  • SPORTS
  • REAL ESTATE
  • CLASSIFIED
  • TOP LOCAL PROFESSIONAL
Seegala / News / PRESS RELEASE / uMotif to Showcase Modern eConsent and eCOA Platform to Support the Pivotal Patient-Site Relationship in Clinical Trials at Fall 2025 Life Sciences Conferences

uMotif to Showcase Modern eConsent and eCOA Platform to Support the Pivotal Patient-Site Relationship in Clinical Trials at Fall 2025 Life Sciences Conferences


Senior executives from uMotif – provider of a modern, all-in-one eConsent/eCOA platform to power clinical trials and real-world studies – share their unmatched knowledge and perspective on bolstering the patient-site connection to improve clinical research at life science industry events this Autumn


Post this

September

  • DPHARM, Loews Hotel Philadelphia PA, September 16-17
  • SCDM Annual Conference, Baltimore MD Convention Center, September 27-30. On September 29, 11:15am-12:15pm, Room 341+342 – uMotif Chief Patient Officer/Co-Founder Bruce Hellman co-hosts an interactive session, “Getting the Most from Technology to Strengthen the Patient-Site Relationship, Reduce Site Burden, and Pave the Way for the Use of AI.”
  • SCRS Global Site Solutions Summit 2025, Orlando FL, September 29-October 1. uMotif is a Performance Sponsor.

October

  • SCOPE Europe 2025, InterContinental (Fira Center) Barcelona, Spain, October 14-15. On October 14, 9:50am, as part of the Clinical Data Strategy and AI Innovation Track, Chief Scientific Officer Florence Mowlem PhD will present, “Why Are eCOA Studies Still So Hard? Can AI Help Solve the Operational and Implementation Challenges?”
  • 17th Annual Outsourcing in Clinical Trials New England 2025, Encore Boston Harbor, Boston MA, October 15-16
  • 13th Annual Outsourcing in Clinical Trials Nordics, October 21-22, Clarion Hotel and Congress Copenhagen Airport, Copenhagen

November

  • CNS Summit, Encore Boston Harbor, Boston MA, November 2-5 – CEO Steve Rosenberg, Chief Scientific Officer Florence Mowlem PhD, and Chief Operating Officer Andrea Valente will present.

To arrange a meeting with a uMotif executive at any of these events, email [email protected]

About uMotif

Putting patients first is in uMotif’s DNA. The modern uMotif eCOA platform delivers faster, high-quality clinical trials and real-world studies by putting patients at the core of research. Combined with uMotif’s robust site tools — including consent management, site productivity, and trial awareness — the platform strengthens the patient-site relationship, which is key to improving eCOA compliance and retention. With cloud hosting in the US, Europe, and China, the GCP, 21 CFR Part 11 and GDPR-compliant platform supports all study phases and indications. Visit www.umotif.com

Media Contact

Brenda Nashawaty, uMotif Ltd, 1 6176883253, [email protected], www.umotif.com

Elaine Maynard, uMotif Ltd, 1 6176883253, [email protected], www.umotif.com

SOURCE uMotif Ltd



Source link

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Previous Post

Costco recalls prosecco bottles prone to suddenly shattering without warning

Next Post

Awake Is a Smart Alarm Clock to Help You Start the Day on the Right Foot

Seegala
Follow us
  • About us
  • Amazon Affiliate disclaimer
  • Anti Spam Policy
  • Copyright Notice
  • Disclaimer
  • DMCA Compliance
  • Social Media Disclaimer
  • Terms and Conditions

Copyright © 2024 Seegala